PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-12-07

Date Title Company
07-Dec-2019 Oncopeptides Presents Updated Efficacy and Safety Data from Pivotal Phase 2 HORIZON Study in Patients With RRMM at ASH Annual Meeting 2019 Oncopeptides AB
07-Dec-2019 Janssen to Acquire Investigational Bermekimab from XBiotech Janssen Pharmaceutical Companies of Johnson & Johnson
07-Dec-2019 Janssen to Acquire Investigational Bermekimab from XBiotech Janssen Pharmaceutical Companies of Johnson & Johnson